Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Elyria › NPI 1841299039
Hospital

Emh Regional Medical Center

Emh Regional Medical Center was paid $41.46M by Medicaid between Jan 2018 and Dec 2024, across 347 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.

33Billing provider infoEMH REGIONAL MEDICAL CENTER
ELYRIA, OH 44035
33aNPI1841299039assigned 07/19/2005
28Total paid$41.46M
24GClaims999,966
24DCodes billed347
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#27 of 101
Median peer was paid$22.32M
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official SCHILLERO, ANTHONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018151,916$5.29M
2019111,871$4.24M
202075,654$4.38M
202183,693$4.32M
202284,627$4.33M
2023282,972$11.40M
2024incomplete209,233$7.51M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 20% 71,111 67,094 $8.27M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 12% 37,894 34,497 $5.05M
96361 Intravenous infusion, hydration; each additional hour 10% 13,859 11,606 $4.32M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.4% 27,110 23,788 $3.47M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.1% 15,740 14,343 $2.13M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 4.5% 18,107 15,605 $1.87M
70450 Computed tomography, head or brain; without contrast material 3.9% 6,544 5,504 $1.63M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.3% 19,056 6,865 $1.38M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 3.1% 9,291 8,512 $1.27M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 5,522 4,522 $1.27M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.7% 4,804 3,227 $708K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.4% 2,243 1,879 $580K
335 more codes
71275 Computed tomographic angiography, chest, with contrast material 1.1% 1,812 $470K
20610 1.1% 3,376 $459K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 3,664 $398K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,309 $393K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 1,603 $390K
80053 Comprehensive metabolic panel <1% 45,659 $360K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,628 $354K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,176 $353K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,742 $336K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,985 $249K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 602 $222K
11043 <1% 842 $195K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,136 $190K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 295 $188K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,619 $174K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,329 $162K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 734 $162K
G0378 Hospital observation service, per hour <1% 2,928 $160K
11045 <1% 661 $152K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 5,990 $118K
80048 Basic metabolic panel (calcium, ionized) <1% 15,438 $112K
71046 Radiologic examination, chest; 2 views <1% 11,050 $105K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 9,353 $100K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,679 $96K
73610 <1% 3,684 $89K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 31,139 $89K
76770 <1% 524 $83K
97161 <1% 2,001 $79K
93017 <1% 932 $77K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 5,010 $73K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 799 $70K
73110 <1% 2,828 $69K
73630 <1% 3,705 $68K
95886 <1% 244 $67K
97113 <1% 880 $66K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 804 $64K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,669 $60K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 2,029 $60K
20526 <1% 301 $57K
73140 <1% 1,998 $56K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,262 $53K
20611 <1% 228 $53K
87631 <1% 572 $52K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 501 $52K
84484 <1% 21,651 $52K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 61,096 $50K
73130 <1% 2,638 $50K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,667 $49K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 187 $47K
70491 <1% 162 $47K
73564 <1% 2,200 $47K
71250 <1% 597 $46K
12001 <1% 290 $45K
93971 <1% 719 $45K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 280 $42K
71045 Radiologic examination, chest; single view <1% 14,805 $41K
73030 <1% 2,076 $40K
97165 <1% 834 $38K
83605 <1% 13,252 $37K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,722 $35K
72110 <1% 763 $35K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,140 $33K
86850 <1% 1,718 $33K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,169 $32K
82607 <1% 1,246 $31K
80320 <1% 1,748 $31K
70551 Magnetic resonance imaging, brain; without contrast material <1% 247 $31K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 10,044 $29K
72131 <1% 543 $29K
25600 <1% 104 $29K
76536 <1% 272 $29K
73560 <1% 1,096 $28K
76642 <1% 239 $27K
70486 <1% 596 $27K
36415 Collection of venous blood by venipuncture <1% 25,273 $26K
84443 Thyroid stimulating hormone (TSH) <1% 2,715 $26K
93970 <1% 225 $25K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 28,266 $25K
93458 <1% 27 $24K
76830 Ultrasound, transvaginal <1% 997 $24K
82805 <1% 822 $24K
J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg <1% 1,579 $24K
99215 Doctor's office visit, returning patient (complex) <1% 285 $24K
93880 <1% 297 $24K
73562 <1% 838 $23K
72125 Computed tomography, cervical spine; without contrast material <1% 1,952 $23K
83880 <1% 4,666 $22K
73502 <1% 1,082 $22K
70496 <1% 100 $22K
80061 Lipid panel <1% 2,028 $22K
86900 <1% 1,881 $21K
93975 <1% 145 $21K
73221 <1% 119 $21K
97162 <1% 574 $21K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 74 $19K
74018 <1% 468 $19K
73080 <1% 806 $19K
20550 <1% 125 $18K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 943 $18K
85027 <1% 4,396 $18K
72100 <1% 672 $18K
87040 <1% 2,281 $17K
96367 <1% 453 $17K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,261 $14K
93296 <1% 783 $13K
64721 <1% 14 $13K
96375 Therapeutic injection; each additional sequential IV push <1% 20,469 $13K
27786 <1% 42 $13K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 32 $12K
29075 <1% 89 $12K
87510 <1% 724 $11K
74174 <1% 271 $11K
90715 <1% 754 $11K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 376 $11K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 9,636 $11K
73590 <1% 643 $10K
82947 <1% 6,862 $10K
81001 <1% 20,841 $10K
83036 Hemoglobin; glycosylated (A1C) <1% 1,241 $10K
81003 <1% 17,982 $9K
72050 <1% 203 $9K
95910 <1% 87 $9K
87660 <1% 713 $9K
87480 <1% 724 $9K
74019 <1% 141 $8K
83735 <1% 8,723 $8K
85610 <1% 11,132 $8K
85379 <1% 2,476 $8K
86780 <1% 323 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,674 $8K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,009 $7K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,291 $7K
73700 <1% 61 $7K
84702 <1% 4,551 $7K
96376 <1% 2,822 $7K
87205 <1% 1,486 $7K
73090 <1% 410 $7K
86901 <1% 1,890 $7K
87800 <1% 564 $6K
97535 Self-care/home management training, each 15 minutes <1% 259 $6K
99152 <1% 475 $6K
82570 <1% 518 $6K
95816 <1% 45 $5K
11046 <1% 31 $5K
70498 <1% 102 $5K
72040 <1% 167 $5K
83690 <1% 13,413 $5K
J3490 Unclassified drugs <1% 3,024 $5K
12002 <1% 30 $4K
94726 <1% 82 $4K
93298 <1% 254 $4K
72128 <1% 174 $4K
97116 <1% 258 $4K
80076 <1% 2,202 $4K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 312 $3K
82077 <1% 2,731 $3K
86140 <1% 1,363 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 6,571 $3K
82043 <1% 491 $3K
84156 <1% 491 $3K
97016 <1% 84 $3K
10060 <1% 17 $3K
95861 <1% 15 $3K
20600 <1% 19 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 110 $3K
84439 <1% 224 $3K
87081 <1% 1,318 $3K
J1815 Injection, insulin, per 5 units <1% 335 $2K
84703 <1% 4,826 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 860 $2K
12011 <1% 15 $2K
85730 <1% 4,284 $2K
73552 <1% 123 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 8,083 $2K
94729 <1% 106 $2K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 137 $2K
80143 <1% 2,127 $2K
81025 <1% 5,945 $2K
82550 <1% 2,125 $2K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 12 $2K
87070 <1% 1,112 $2K
87077 <1% 667 $2K
J7030 Infusion, normal saline solution , 1000 cc <1% 15,971 $2K
C1889 Implantable/insertable device, not otherwise classified <1% 25 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 121 $2K
76870 <1% 75 $2K
87634 <1% 881 $2K
72170 <1% 392 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 163 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,423 $1K
87186 <1% 1,076 $1K
82150 <1% 2,010 $1K
87340 <1% 102 $1K
88142 <1% 97 $1K
86803 <1% 90 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,465 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 400 $1K
J3535 Drug administered through a metered dose inhaler <1% 201 $1K
82330 <1% 613 $1K
76937 <1% 33 $1K
94150 <1% 48 $1K
87075 <1% 1,718 $1K
A9270 Non-covered item or service <1% 8,968 $1K
73660 <1% 28 $953.00
73000 <1% 59 $910.34
80179 <1% 2,084 $882.76
99153 Mod sedat endo service >5yrs <1% 152 $877.28
85007 <1% 119 $823.47
93922 <1% 12 $780.88
94200 <1% 34 $775.73
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,055 $742.72
J3300 Injection, triamcinolone acetonide, preservative free, 1 mg <1% 40 $734.47
C9113 Injection, pantoprazole sodium, per vial <1% 915 $695.01
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,023 $626.85
84132 <1% 1,026 $607.41
83970 <1% 18 $578.82
86762 <1% 30 $575.86
82746 <1% 41 $554.67
88300 <1% 12 $531.91
73060 <1% 87 $522.18
83655 <1% 14 $513.63
77066 Tomosynthesis, mammo <1% 47 $512.86
82728 <1% 38 $480.50
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 252 $477.97
84100 <1% 612 $471.30
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,259 $466.89
85018 <1% 620 $443.69
86141 <1% 996 $433.08
86787 <1% 41 $430.55
72120 <1% 113 $429.43
82435 <1% 549 $424.51
29125 <1% 91 $404.23
84153 <1% 18 $397.60
77062 <1% 13 $391.49
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,365 $379.36
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 1,696 $373.55
85652 <1% 546 $369.29
93297 <1% 17 $338.05
93280 <1% 29 $331.54
82950 <1% 38 $328.21
83721 <1% 28 $326.41
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 935 $326.22
J1644 Injection, heparin sodium, per 1000 units <1% 1,312 $320.86
82248 <1% 1,077 $299.08
80069 <1% 21 $294.87
74022 <1% 26 $292.77
83540 <1% 45 $287.01
87807 <1% 1,111 $276.56
88112 <1% 12 $271.02
76801 <1% 103 $260.72
J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg <1% 62 $254.05
83550 <1% 37 $247.44
90686 <1% 19 $240.34
84295 <1% 551 $237.38
36600 <1% 245 $230.05
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,962 $228.79
J3370 Injection, vancomycin hcl, 500 mg <1% 436 $209.76
J7999 Compounded drug, not otherwise classified <1% 285 $204.39
93290 <1% 37 $203.75
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,433 $191.66
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,564 $180.36
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,494 $153.65
82010 <1% 243 $149.93
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,351 $134.58
G0404 Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination <1% 147 $130.22
J3010 Injection, fentanyl citrate, 0.1 mg <1% 4,047 $113.41
80329 <1% 180 $109.83
0753T <1% 72 $109.47
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 247 $105.85
J2704 Injection, propofol, 10 mg <1% 3,551 $105.58
29515 <1% 13 $100.43
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 335 $98.19
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 1,148 $89.07
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 403 $85.01
J7070 Infusion, d5w, 1000 cc <1% 124 $80.67
82948 <1% 201 $62.41
J8540 Dexamethasone, oral, 0.25 mg <1% 761 $58.71
84550 <1% 34 $57.84
A4217 Sterile water/saline, 500 ml <1% 920 $57.49
J2060 Injection, lorazepam, 2 mg <1% 406 $55.65
94762 <1% 26 $53.94
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 2,138 $53.77
J2550 Injection, promethazine hcl, up to 50 mg <1% 503 $53.70
73100 <1% 154 $52.76
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,346 $52.00
94761 <1% 1,278 $51.99
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,013 $51.83
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 174 $50.71
J3480 Injection, potassium chloride, per 2 meq <1% 452 $49.96
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,065 $49.03
J1630 Injection, haloperidol, up to 5 mg <1% 200 $41.74
72114 <1% 38 $40.31
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,144 $35.50
J0690 Injection, cefazolin sodium, 500 mg <1% 509 $33.73
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,032 $33.11
C1769 Guide wire <1% 232 $29.16
J7050 Infusion, normal saline solution, 250 cc <1% 906 $25.97
86308 <1% 76 $25.74
J7060 5% dextrose/water (500 ml = 1 unit) <1% 485 $22.89
J0360 Injection, hydralazine hcl, up to 20 mg <1% 69 $21.74
J1171 Injection, hydromorphone, 0.1 mg <1% 181 $19.00
81002 <1% 20 $12.39
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg <1% 29 $11.58
J0780 Injection, prochlorperazine, up to 10 mg <1% 29 $11.18
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 500 $10.95
J2470 Injection, pantoprazole sodium, 40 mg <1% 123 $10.78
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 490 $8.21
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 143 $6.79
76377 <1% 833 $5.27
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 143 $4.96
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 50 $4.00
J1920 Injection, labetalol hydrochloride, 5 mg <1% 37 $3.98
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 96 $2.50
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 33 $2.34
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 183 $0.48
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 316 $0.32
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 158 $0.00
82803 0% 43 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 271 $0.00
94760 0% 292 $0.00
A9698 Non-radioactive contrast imaging material, not otherwise classified, per study 0% 56 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 12 $0.00
G0269 Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug) 0% 23 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 611 $0.00
87185 0% 14 $0.00
01810 0% 13 $0.00
94664 0% 42 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 41 $0.00
00840 0% 179 $0.00
00811 0% 37 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 64 $0.00
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 0% 18 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 54 $0.00
Q9957 Injection, perflutren lipid microspheres, per ml 0% 12 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHILLERO, ANTHONY (DIRECTOR, FP&A)
Same official

Other billing entities under SCHILLERO, ANTHONY

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.